Clear 618 Results Filter Filter Results Type: Press Release Abiomed Showcases Impella® Technology that Enables Heart Recovery at ACC with 25 Presentations Type: Press Release Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures Type: Press Release Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Womens Initiative for Heart Recovery Type: Press Release Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock Type: Press Release Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million Up 34% Over Prior Year Type: Press Release Abiomed Third Quarter Fiscal 2018 Earnings and Conference Call Notification Type: Press Release Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154 Million Up 34% Over Prior Year Type: Press Release Abiomed to Present at the 36th Annual JP Morgan Healthcare Conference Type: Press Release Abiomed Announces First Patient Treated with Impella® in Japan Type: Press Release Abiomed Announces Q2 FY 2018 Revenue of $1328 Million Up 29% and Record US Patient Utilization Up 33% … 32 33 34 35 …
